SectorBiological Technology
Established Date--
Listing Date30/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees70
Fiscal Year Ends31/12
Security TypeCommon stock
Office address171 Oyster Point Boulevard
Suite 500
South San Francisco
CA 94080
Business
IntroductionTenaya Therapeutics, Inc., was incorporated in Delaware in August 2016. The company is a preclinical stage biotechnology company focused on discovering, developing and delivering treatments for the underlying drivers of heart disease. The company is advancing product candidates from three distinct but interrelated product platforms: gene therapy, cell regeneration and precision medicine.
